Appeal No. 2006-1844 7 Application No. 10/080,292 With respect to claims 19 and 20 we note appellants’ argument on page 5 of the supplemental brief that Verreet cannot teach the size limitations claimed in claims 19 and 20. We concur. We reverse the section 102 rejection of claims 19 and 20 based on the Verreet patent. We note that the rejections of claims 21, 22 and 23 under section 103 are not argued on page 9 of the supplemental brief apart from a limitation of the independent claim 17 from which they depend. Thus claim 21 falls with claim 17 as unpatentable over Verreet in view of Cragg, and claims 22 and 23 fall with claim 17 as unpatentable over Verreet in view of Cragg and any of Bolger, Saadat, or Henalla. Finally, with respect to claim 24 we agree that none of the applied prior art appears to disclose a patient- operated device in combination with a delivery system. Indeed, the examiner has not so indicated. Accordingly, the rejection of claim 24 under section 103 is reversed. SUMMARY All rejections of claims 1-12 and 14-16 are reversed. The rejections of claims 17-20 under section 102 as anticipated by Siramanne are reversed. The rejection of claim 17 under section 102 as anticipated by Donadio is affirmed.Page: Previous 1 2 3 4 5 6 7 8 9 10 NextLast modified: November 3, 2007